NO953457L - Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse - Google Patents

Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse

Info

Publication number
NO953457L
NO953457L NO953457A NO953457A NO953457L NO 953457 L NO953457 L NO 953457L NO 953457 A NO953457 A NO 953457A NO 953457 A NO953457 A NO 953457A NO 953457 L NO953457 L NO 953457L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparations
somatostatin peptides
somatostatin
peptides
Prior art date
Application number
NO953457A
Other languages
English (en)
Other versions
NO316569B1 (no
NO953457D0 (no
Inventor
Rainer Albert
Christian Bruns
Peter Smith-Jones
Barbara Stolz
Gisbert Weckbecker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO953457D0 publication Critical patent/NO953457D0/no
Publication of NO953457L publication Critical patent/NO953457L/no
Publication of NO316569B1 publication Critical patent/NO316569B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO953457A 1994-09-06 1995-09-04 Somatostatinpeptider, farmasøytiske preparater derav, og anvendelse derav, kit for anvendelse ved behandling av somatostatinreseptorpositiv tumorinvasivitet eller symptomer forbundet med tumorvekst, samt farmasøytisk preparat for samme formål NO316569B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417873A GB9417873D0 (en) 1994-09-06 1994-09-06 Organic compounds

Publications (3)

Publication Number Publication Date
NO953457D0 NO953457D0 (no) 1995-09-04
NO953457L true NO953457L (no) 1996-03-07
NO316569B1 NO316569B1 (no) 2004-02-23

Family

ID=10760870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953457A NO316569B1 (no) 1994-09-06 1995-09-04 Somatostatinpeptider, farmasøytiske preparater derav, og anvendelse derav, kit for anvendelse ved behandling av somatostatinreseptorpositiv tumorinvasivitet eller symptomer forbundet med tumorvekst, samt farmasøytisk preparat for samme formål

Country Status (31)

Country Link
US (2) US6183721B1 (no)
EP (1) EP0714911B1 (no)
JP (1) JP3054346B2 (no)
KR (1) KR100364111B1 (no)
CN (1) CN1185252C (no)
AT (1) ATE199561T1 (no)
AU (1) AU703057B2 (no)
BR (1) BR9503936A (no)
CA (1) CA2157530C (no)
CO (1) CO4410344A1 (no)
CZ (1) CZ287012B6 (no)
DE (1) DE69520256T2 (no)
DK (1) DK0714911T3 (no)
ES (1) ES2157309T3 (no)
FI (1) FI117424B (no)
GB (1) GB9417873D0 (no)
GR (1) GR3035997T3 (no)
HU (1) HU218284B (no)
IL (1) IL115154A (no)
NO (1) NO316569B1 (no)
NZ (1) NZ272919A (no)
PE (1) PE41496A1 (no)
PL (1) PL182434B1 (no)
PT (1) PT714911E (no)
RU (1) RU2156774C2 (no)
SG (1) SG50356A1 (no)
SI (1) SI0714911T1 (no)
SK (1) SK283774B6 (no)
TR (1) TR199501094A2 (no)
TW (1) TW387898B (no)
ZA (1) ZA957475B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
AT405906B (de) * 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
CN1551767A (zh) 2001-02-19 2004-12-01 ��˹��ŵ�� 癌症的治疗
BR0207315A (pt) * 2001-02-26 2004-02-10 Bristol Myers Squibb Pharma Co Análogos de ácido ascórbico para metalorradiofármacos
AU2002305845B2 (en) * 2001-06-08 2006-03-30 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
US7211250B2 (en) 2002-07-18 2007-05-01 Helix Biopharma Corporation Method and composition for inhibiting cancer cell growth
JP2006522100A (ja) * 2003-03-10 2006-09-28 バイオジェン アイデック インク 標的化ペプチドに対するチオール媒介性薬物結合
EP1771205B1 (en) 2004-06-18 2016-10-26 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
US20100029911A1 (en) * 2004-11-24 2010-02-04 Aplagen Gmbh Method For Solid-Phase Peptide Synthesis And Purification
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
US20140170068A1 (en) 2011-03-11 2014-06-19 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
EP2922578B1 (en) 2012-11-21 2018-12-12 Serene, Llc Tin-117m comprising somatostatin receptor binding compounds
CN103275189B (zh) * 2013-06-06 2014-08-06 深圳翰宇药业股份有限公司 一种用于肽树脂的裂解液及其在固相裂解合成生长抑素中的应用
AU2014336638C1 (en) * 2013-10-18 2020-09-17 Novartis Ag Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
EP3383920B1 (en) 2015-11-30 2024-01-10 The Regents of the University of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
US11235076B2 (en) 2016-08-29 2022-02-01 Fred Hutchinson Cancer Research Center Chelating platform for delivery of radionuclides
EP3538551A4 (en) 2016-11-10 2020-11-11 Fortis Therapeutics, Inc. CD46 SPECIFIC EFFECTOR CELLS AND USES THEREOF
CA3050094C (en) 2017-01-12 2024-01-02 Radiomedix Inc. Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes
TW202015744A (zh) * 2018-06-21 2020-05-01 法商艾普森藥品公司 用於放射性醫藥之含有體抑素類似物之組成物
TW202547563A (zh) * 2018-06-21 2025-12-16 德商愛利穆治療有限公司 用於放射性醫藥之含有體抑素類似物之組成物
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US20200030466A1 (en) 2018-07-25 2020-01-30 Advanced Accelerator Applications (Italy) Srl Stable, concentrated radionuclide complex solutions
EP3972627A4 (en) 2019-05-20 2023-06-21 Endocyte, Inc. Methods for preparing psma conjugates
JP2023534765A (ja) 2020-08-07 2023-08-10 フォーティス セラピューティクス，インク． 免疫複合体を標的とするｃｄ４６およびその使用方法
WO2022106629A1 (en) 2020-11-19 2022-05-27 Novartis Ag Synthesis of prostate specific membrane antigen (psma) ligands
JPWO2025058000A1 (no) 2023-09-13 2025-03-20

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US5006643A (en) 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes
DE3728600A1 (de) 1987-08-27 1989-03-09 Hoechst Ag Verfahren zur markierung von substanzen mit technetium oder rhenium
ATE134999T1 (de) * 1988-05-25 1996-03-15 Us Commerce Makrocyclische chelate und verwendungsverfahren
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
WO1991004755A1 (en) 1989-09-29 1991-04-18 Neorx Corporation Methods for reducing non-target retention of immunoconjugates and metabolites thereof
JPH07505621A (ja) * 1992-03-25 1995-06-22 マリンクロッド・インコーポレイテッド 外科手術中における腫瘍組織の検出および探知法
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
NO940080L (no) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav
CA2179990A1 (en) * 1994-01-12 1995-07-20 Gary Robert Bower Biological targeting agents
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
TW387898B (en) 2000-04-21
DE69520256D1 (de) 2001-04-12
ATE199561T1 (de) 2001-03-15
PE41496A1 (es) 1996-10-14
PL182434B1 (pl) 2002-01-31
FI117424B (fi) 2006-10-13
SK108895A3 (en) 1996-06-05
JP3054346B2 (ja) 2000-06-19
FI954147A0 (fi) 1995-09-04
DK0714911T3 (da) 2001-07-09
DE69520256T2 (de) 2001-08-09
HUT72895A (en) 1996-06-28
NO316569B1 (no) 2004-02-23
AU3041495A (en) 1996-03-21
GB9417873D0 (en) 1994-10-26
KR960010683A (ko) 1996-04-20
US6277356B1 (en) 2001-08-21
CZ287012B6 (en) 2000-08-16
FI954147L (fi) 1996-03-07
ZA957475B (en) 1997-03-06
ES2157309T3 (es) 2001-08-16
EP0714911A2 (en) 1996-06-05
NO953457D0 (no) 1995-09-04
HU218284B (en) 2000-07-28
GR3035997T3 (en) 2001-09-28
CN1185252C (zh) 2005-01-19
CN1127259A (zh) 1996-07-24
PT714911E (pt) 2001-08-30
SI0714911T1 (en) 2001-08-31
TR199501094A2 (tr) 1996-06-21
SK283774B6 (sk) 2004-01-08
RU2156774C2 (ru) 2000-09-27
HU9502577D0 (en) 1995-11-28
SG50356A1 (en) 2000-11-21
CZ226395A3 (en) 1996-03-13
EP0714911B1 (en) 2001-03-07
US6183721B1 (en) 2001-02-06
KR100364111B1 (ko) 2003-02-05
NZ272919A (en) 1996-12-20
CA2157530C (en) 2007-04-03
AU703057B2 (en) 1999-03-11
PL310274A1 (en) 1996-03-18
EP0714911A3 (en) 1996-08-21
CO4410344A1 (es) 1997-01-09
CA2157530A1 (en) 1996-03-07
BR9503936A (pt) 1996-09-24
IL115154A (en) 2000-08-13
IL115154A0 (en) 1995-12-31
JPH0881498A (ja) 1996-03-26

Similar Documents

Publication Publication Date Title
NO953457D0 (no) Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse
DK0610487T3 (da) Nye aminosyrederivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser
DK290986A (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK562888D0 (da) Aminomethyl-oxooxazolidinyl-cycloalkylbenzenderivater, fremstilling deraf, praeparater indeholdende disse og deres anvendelse som antibakterielle midler
DK0567966T3 (da) Cykliske aminoderivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser
DK231687A (da) Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser
DK165693C (da) 2-(n-substitueret guanidino)-4-heteroarylthiazol-forbindelser og farmaceutiske praeparater indeholdende disse
DK610284D0 (da) 2-phenyl-imidazolderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DK195087D0 (da) Heterocyclisk og alkansulfonamidophenyl-substituerede aminer og deres anvendelse til fremstilling af antiarrytmiske laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser
DK166279C (da) 3,4-dihydro-2h-benzooebaapyranderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DE3688087D1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK166878C (da) Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser
DK90189A (da) Trisubstituerede aminer, fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse forbindelser
DK106287D0 (da) Glycero-3(2)-phospho-l-serin-derivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
NO871375D0 (no) Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse.
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DK189786D0 (da) 4-aminoalkylidensubstituerede 3-aryl-5(4h)-isoxazoloner, fremgangsmaader til fremstilling deraf, samt laegemidler indeholdende disse forbindelser og deres anvendelse
DK141784A (da) Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK127086A (da) Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
GB8819545D0 (en) New benzazole derivatives processes for their preparation & pharmaceutical preparations containing such compounds & use thereof
DK127186D0 (da) Imidazo-isochinolin- og imidazo-thienopyridinforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
DK276690A (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK162228C (da) Substituerede 7-aminocarbonyloxy-2,3,4,5-tetrahydro-1h-3-benzazepiner, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne

Legal Events

Date Code Title Description
MK1K Patent expired